Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Latest News
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
Media Centre
>
Coverage
Overview
Latest News
Video
Coverage
Coverage
1-May-2023
Kazia Therapeutics appoints Dr John Friend as new CEO
4-Apr-2023
Kazia Therapeutics to present new pipeline molecule data at AACR 2023
6-Mar-2023
Kazia Therapeutics forms clinical collaboration for Australian Phase 2 study of paxalisib, targeting childhood cancers
28-Feb-2023
Kazia Therapeutics raises A$7 million to fund R&D pipeline
6-Feb-2023
After a successful $4.5 million cap raise and with cancer trial results to come, Kazia is optimistic for 2023
31-Jan-2023
ASX rose 6.2% in January: Aus shares closed the day 0.07% lower
31-Jan-2023
High cost of living causes a fall in retail sales: ASX up 0.22% at noon
17-Jan-2023
Kazia Therapeutics CEO talks $4.5 million capital raise
16-Jan-2023
Kazia Therapeutics raising $4.5 million in placement; launches SPP
20-Dec-2022
Kazia Therapeutics exploring use of lead asset in other cancers: Edison Investment Research
Click here for archives
